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Summary 
BET (Bromodomain and Extra Terminal domain) family proteins are unique among 
bromodomain-containing proteins in that they, not only associate to acetylated 
chromatin in interphase, but also remain attached to chromosomes during mitosis. 
Although the two tandem bromodomains are essential to display this behavior they do 
not suffice. In this work we report that a small conserved domain, the motif B, is also 
required for that. A deletion mutant of this domain dissociates from mitotic 
chromosomes. However, inhibition of histone deacetylases alleviates dissociation. We 
also show that motif B-dependent association to chromosomes is not restricted to 
mitosis. Interestingly, our results indicate that the motif B constitutes a surface for 
homo- and hetero-dimerization between BET proteins. Finally, linked to the prominent 
role BET proteins play in cell proliferation, we report that ectopic expression of the 
family member Brd2 interferes with neuronal differentiation in P19 cells and in the 
vertebrate neural tube, probably due to preservation of adequate levels of cyclins A2 
and D1. By contrast, a deletion mutant of the motif B fails to perform in this way, 
highlighting the relevance of this domain for Brd2 function. 
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Introduction 
Acetylation and other histone modifications control essential transcriptional regulatory 
processes in the cell. Combinatorial display of these modifications modulates the 
docking characteristics of chromatin to recruit a huge variety of effector proteins that 
induce changes in its structure and thereby in gene transcription (Jenuwein and Allis, 
2001). Precise recognition of these modifications by specialized modules in effector 
proteins is critical for accurate transcriptional control. Recognition of histone 
acetylation by the bromodomain illustrates this scenario. Bromodomains are present in a 
number of chromatin-associated proteins, which include histone acetyltransferases 
(HATs), ATP-dependent chromatin remodeling factors and proteins of the BET 
(Bromodomain and Extra Terminal domain) family (Jeanmougin et al., 1997; Yang, 
2004). 
 The BET family of proteins in mammals comprises Brd2, Brd3, Brd4 and Brdt. 
Except this last, which is restricted to the male germ line, rest of the members are 
widely expressed in all tissues. Vertebrate BET proteins are characterized by the 
presence of two tandem bromodomains at the N-terminus and an exclusive Extra 
Terminal (ET) domain at the C-terminus. The ET region includes the NET (N-terminal 
Extra Terminal) domain, and the C-terminal SEED motif (Florence and Faller, 2001). 
While function of bromodomains has been well characterized, function of other 
domains has been poorly investigated (Denis et al., 2000; Rahman et al., 2011). It is 
well established that bromodomains of BET proteins bind to acetylated chromatin. 
While Brd2 seems to preferentially bind histone H4 at the mono-acetylated state 
(acetyl-K12), Brd4 and Brdt more efficiently recognize di-acetylated histone H4, at 
K5/K12 and K5/K8 positions, respectively (Dey et al., 2003; Ito et al., 2011; Kanno et 
al., 2004; LeRoy et al., 2008; Moriniere et al., 2009; Sasaki et al., 2009). In addition, 
binding of BET members to acetylated proteins, others than histones, has also been 
reported (Gamsjaeger et al., 2011; Huang et al., 2009; Lamonica et al., 2011). 
Acetylation of histones correlates with gene activation (Hebbes et al., 1988), and in this 
respect, BET proteins have been described as transcriptional activators with a prominent 
role in the control of cell cycle-associated genes. Brd2 has been implicated in 
controlling the expression of cyclins A2 and D1 (LeRoy et al., 2008; Sinha et al., 2005). 
Brd4 has been involved in controlling expression of cyclin D1 and other G1-associated 
genes required for progression to the S phase (Mochizuki et al., 2008; Yang et al., 
2008). A major determinant of Brd4 function is its association with the positive 
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transcription elongation complex P-TEFb (Yang et al., 2005). In contrast to Brd2 and 
Brd3, Brd4 presents an additional C-Terminal Domain (CTD) that is essential for this 
function (Bisgrove et al., 2007). Analysis of knock out mice has revealed that Brd2 and 
Brd4 are essential for embryonic development. Fibroblasts derived from both Brd2- and 
Brd4-deficient animals proliferate more slowly than control ones (Houzelstein et al., 
2002; Shang et al., 2009). Brd4 heterozygous mice display pre- and postnatal growth 
defects associated with a reduced proliferation rate, while nullizygous embryos die 
shortly after implantation (Houzelstein et al., 2002). On the other hand, most Brd2-
deficient embryos die by embryonic day 11.5 (Gyuris et al., 2009; Shang et al., 2009).  
 A striking characteristic of BET proteins is that they remain attached to 
chromosomes during mitosis, suggesting they play a role in the transmission of 
transcriptional memory across cell division (Dey et al., 2003; Kanno et al., 2004). It has 
been reported that integrity of the bromodomains is required for this ability (Dey et al., 
2003; Kanno et al., 2004). However, other bromodomain-containing proteins do not 
associate to mitotic chromosomes (Kruhlak et al., 2001), suggesting that special and/or 
additional structural features in BET proteins should be involved in displaying this 
behavior. Supporting this hypothesis, we found that a conserved region of 47 amino 
acids located between the second bromodomain and the ET region of BET proteins, and 
previously designated as the motif B (Paillisson et al., 2007), is required for attachment 
to mitotic chromosomes. Our results demonstrate that the motif B constitutes a 
dimerization domain, and that function of Brd2 is compromised in its absence. 
 
Results 
A small conserved motif in BET proteins is involved in association to mitotic 
chromosomes 
Bromodomain-containing proteins associate to the chromatin through acetylated 
histones. During mitosis, most proteins, including many bromodomain-containing 
proteins, dissociate from chromatin (Kruhlak et al., 2001). However, proteins from the 
BET family remain attached to mitotic chromosomes (Dey et al., 2003; Kanno et al., 
2004). Then, it is reasonable to speculate that additional structures, others than the 
bromodomains, are implicated in BET-attachment to mitotic chromosomes. To 
investigate this hypothesis we have analyzed the localization of different flag-tagged 
constructions derived from the mouse BET protein Brd2 on mitotic chromosomes of 
P19 cells (Fig. 1A). As occurs for Brd4 (Dey et al., 2003), deletion of bromodomain 1 
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(BD1) displaces Brd2 from mitotic chromosomes (Fig. 1B), indicating that integrity of 
the bromodomains is essential for this function. Similarly, a double Brd2 mutant with 
point mutations Y152K and N428A in BD1 and BD2, respectively, previously shown to 
affect Brd2 functionality (Huang et al., 2007; Nakamura et al., 2007), did not associate 
to mitotic chromosomes (Fig. 1B). However, both bromodomains are not sufficient to 
promote association to mitotic chromosomes, as a construction encompassing both 
intact bromodomains also failed to attach to them (Fig. 1B). Serial deletions from the C-
terminus of Brd2 indicated that a truncated Brd2 protein lacking from amino acid 612 
remained attached to mitotic chromosomes (Fig. 1C). However, deletion from amino 
acid 473 made the protein to appear dissociated (Fig. 1C). The region between amino 
acids 473 and 612 contains an uncharacterized motif of 47 amino acids, designated as 
the motif B (mB), and highly conserved among BET proteins (Paillisson et al., 2007). 
To investigate more precisely the involvement of the motif B in mitotic 
chromosomes attachment we tested a Brd2 construction lacking this domain (∆mB). As 
shown in Fig. 1C, this construction appeared dissociated from chromosomes. By 
contrast, deletions of similar length, N- or C-terminal to the motif B, resulted in no 
alteration of Brd2 localization (Fig. 1C). Finally, we analyzed the effect of motif B 
deletion in the ability of Brd3 and Brd4 to associate to mitotic chromosomes. Similarly 
to Brd2 mutant, Brd3 and Brd4 mutants were also affected in chromosome localization 
(supplementary material Fig. S1A). 
Taken together, our results strongly indicate that the conserved motif B, together 
with the integrity of the bromodomains, is required for attachment of BET proteins to 
mitotic chromosomes. 
 
Efficient recognition of acetylated chromatin by Brd2 requires the motif B 
A detailed analysis of the Brd2 ∆mB construction through the mitosis revealed that 
while this mutant was completely dissociated from chromosomes at prophase and 
metaphase, significant reassociation was observed at late mitosis, as anaphase proceeds 
(Fig. 2A). This dual behavior of the ∆mB construction indicates that mitosis progresses 
in a biphasic manner in relation to the recognition of mitotic chromosomes by Brd2. In 
this respect, it has been reported that significant deacetylation of the chromatin takes 
place at the onset of mitosis (Kruhlak et al., 2001). Indeed, real-time imaging 
experiments have indicated that acetylation of K5/K8 on histone H4 decreases in 
mitosis (Sasaki et al., 2009). However, not all acetylation marks are lost, since 
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acetylation of K12 on histone H4 is maintained (Ito et al., 2011). To investigate how 
acetylation affects association of the ∆mB construction to chromosomes we made use of 
trichostatin A (TSA), which promotes hyperacetylation of chromatin by inhibiting 
histone deacetylases (HDACs). As shown in Fig. 2B, we observed chromosome 
association of the ∆mB protein under these conditions. The same result was obtained 
with ∆mB constructions of Brd3 and Brd4 (supplementary material Fig. S1B). As a 
control, the ∆BD1 construction remained dissociated in the presence of TSA (Fig. 2B). 
Titration of TSA indicated significant Brd2 reassociation at 75 ng/ml and almost 
complete reassociation at 150 ng/ml (supplementary material Fig. S1C). 
 Next, we asked whether relevance of the motif B in Brd2 association to the 
chromatin was restricted to mitosis. In order to elucidate that, we decided to compare 
extraction of transfected WT and mutant Brd2 with increasing salt concentrations from 
exponentially growing cell cultures, which normally contains 94±3% (n= 602) cells in 
interphase. While WT Brd2 required high salt concentrations (520 mM) to be 
completely extracted, most ∆mB was extracted at 100 mM NaCl, comparable to the 
control bromodomain mutant Y152KN428A (Fig. 2C), indicating that requirement of 
the motif B for association to the chromatin is not restricted to mitosis. 
 We next investigated the direct involvement of the motif B in acetyl-histone 
recognition by in vitro pull-down experiments with protein extracts from cells 
transfected with different Brd2 constructions. It has been previously reported that Brd2 
precipitates acetyl-K14 histone H3 (LeRoy et al., 2008). Thus, for pull-down 
experiments we used of a di-acetylated histone H3 peptide that includes this mark. As 
observed in Fig. 2D, the ∆mB construction failed to bind to the acetylated peptide in 
comparison with the wild type although it retained some binding capacity compared to 
the negative control Y152KN428A (Fig. 2D). 
 These results indicate that efficient recognition of the chromatin by Brd2 
requires the motif B, and that this is particularly appreciable under hypoacetylation 
conditions, as it occurs during early mitosis.  
 
The conserved motif B constitutes a dimerization domain 
To get insights into the role of the motif B we performed a yeast two-hybrid screening 
with a bait construction encompassing the motif B of Brd2. We screened an 11-days old 
mouse embryo cDNA library and analyzed about 2·106 transformants. Among them, 
150 showed positive growth on selective medium, and interestingly, 141 corresponded 
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to a prey construction encompassing the motif B of Brd3 (Fig. 3A). As prey and bait 
constructions included additional sequences besides the motif B, we precisely mapped 
the interaction surfaces and found that motif B of Brd2 interacted with motif B of Brd3 
(Fig. 3B). Self-interaction of the Brd2 motif B and other combinations of the different 
BET motives B also resulted positive in the yeast assay (Fig. 3B and supplementary 
material Fig. S2A), suggesting that the motif B constitutes a domain for homo- and 
hetero-dimerization between BET proteins. Direct evidence of the interaction was 
obtained by pull-down assays with purified recombinant proteins, which showed that a 
GST-mB construction efficiently retained flag-mB but not a flag-NET peptide (Fig. 
3C). 
 We next analyzed the relevance of the motif B in Brd2 self-interaction by 
immunoprecipitation assays. We included in our analysis a full Brd2 protein with point 
mutation Y152K, previously shown to affect dimerization of truncated BD1 (Nakamura 
et al., 2007). As shown in Fig. 3D, flag-tagged Brd2 was efficient in precipitating HA-
tagged Brd2, less efficient in precipitating the Y152K and ∆mB proteins, and almost 
ineffective in precipitating the double Y152K∆mB mutant, indicating that the motif B 
was as necessary as the BD1 for Brd2 dimerization. Our analysis revealed that Brd2 
precipitated Brd3 and Brd4 as well (Fig. 3E). Other BET protein combinations also 
showed homo- and hetero-dimerization between BET proteins (supplementary material 
Fig. S2B). We next confirmed the relevance of the motif B for Brd2-Brd3 interaction by 
immunoprecipitation (Fig. 3F). To investigate motif B-mediated dimerization of 
endogenous Brd2 we generated rabbit antibodies against amino acids 698 to 780 at the 
C-terminus of Brd2 (Fig. 3G). Using these antibodies we analyzed precipitated 
endogenous Brd2 in immunoprecipitation experiments with two Brd2 constructions 
lacking the C-terminus, one of them also lacking the motif B. Results revealed that only 
the construction harboring the motif B was efficient in precipitating endogenous Brd2 
(Fig. 3H). Finally, to get evidence of BET homo- and hetero-dimerization in the cell we 
analyzed interaction of Brd2 with itself and with Brd3 by FRET, and significant FRET 
signal was observed for GFP-Brd2/Brd2-RFP and GFP-Brd3/Brd2-RFP combinations, 
compared with the negative control Y152K∆mB (Fig. 4A, B), indicative of protein 
interaction. Interestingly, deletion of just the motif B was sufficient to abrogate the 
positive FRET signal for Brd2 self-interaction (Fig. 4A, B). 
 Our results suggest that dimerization of BET proteins is required for efficient 
recognition of chromatin. Then, we reasoned that overexpression of a truncated 
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construction containing just the Brd2 motif B should interfere with chromatin 
recognition by wild type Brd2. Hence, we analyze attachment to mitotic chromosomes 
of wild type Brd2 in the presence of a GFP-motif B construction, and interestingly we 
found dissociated Brd2 in prophase/metaphase (Fig. 4C). 
 Together, our results indicate that homo- or hetero-dimerization of BET proteins 
through the conserved motif B permits efficient recognition of acetylated chromatin. 
 
Deletion of the motif B impairs Brd2-mediated stimulation of the cell cycle 
It has been previously reported that ectopic Brd2 stimulates progression of the cell cycle 
through cyclin A2 activation (Sinha et al., 2005). Since cyclin D1 has also been reported 
as regulated by Brd2 (LeRoy et al., 2008), we have investigated how transfection of WT 
and ∆mB constructions affects expression levels of cyclin A2 and D1. We found that 
while WT or ∆NmB Brd2 have a positive effect in cyclins expression, the ∆mB protein 
has no effect, similar to the Y152KN428A mutant (Fig. 5A). These results correlated 
with those from chromatin immunoprecipitation (ChIP) experiments involving cyclins 
A2 and D1 promoters (Fig. 5B). Thus, ChIP experiments showed a similar presence of 
WT or ∆NmB protein in the promoters, while ∆mB or Y152KN428A were absent. 
Addition of retinoic acid (RA) to P19 cells induces cell cycle arrest (Pao et al.). In 
agreement with results described in Fig. 5A, B, we have observed that, while adding RA 
to control P19 cells or to cells transfected with the ∆mB or the Y152KN428A 
construction leads to downregulation of cyclins A2 and D1, transfection of the WT or 
the ∆NmB construction prevents downregulation (Fig. 5C). By analyzing cell cycle 
profiles we remarked an increase of cells in the G1 phase upon RA treatment, 
irrespective of the presence of the ∆mB protein or the Y152KN428A control (Fig. 5D, 
E). Thus, ratio of cells in G1 respect to cells in the S, G2 and M phases increased from 
about 0.7 to near 1.5, indicating that cells in G1 increased from 40% to 60%. By 
contrast, the presence of the WT or the ∆NmB protein impaired these RA effects, 
resulting in a profile similar to that of non-treated cells (Fig. 5D, E). These results 
indicate that the ∆mB protein fails to stimulate the cell cycle and to interfere with RA-
induced arrest of the cell cycle, as WT Brd2 does. 
 Based in our results, it is tempting to speculate that Brd2 overexpression, by 
stimulating the cell cycle, might impair cell differentiation. To investigate this 
hypothesis we choose a neuronal differentiation model. A standard approach to study 
neuronal differentiation consists in transfecting P19 cells with E12 and NeuroD2 
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expression constructs to evaluate the presence of the neuronal marker ßIII-tubulin in 
transfected cells (Farah et al., 2000; Seo et al., 2005).  Results indicated that transfection 
of the ∆mB construction had little effect in neuronal differentiation, compared with the 
significant reduction (42% decrease) mediated by WT Brd2 (Fig. 6A, C). Finally, we 
decided to confirm these results in an animal model, and without forcing differentiation. 
Thus, we turned to the chick embryo and used the technique of electroporation to 
transfect half of the neural tube with WT and ∆mB constructions of Brd2. As Fig. 6B, C 
indicates, 30 h after electroporation, about 35% of transfected proliferating neuroblasts 
in the ventricular zone (VZ), which express a GFP control construct, have naturally 
exited the cell cycle and migrated to the neural tube margin, or mantle layer (ML), 
where they install to differentiate into neurons. While electroporation of WT Brd2 
severely interfered with ML migration of transfected neuroblasts, indicative of neuronal 
differentiation impairment, the ∆mB construction had no effect (Fig. 6B, C). Thus, 
these results indicate that the conserved motif B is required for Brd2-mediated 
interference of neuronal differentiation. 
 
Discussion 
Since many bromodomain containing proteins dissociate from chromatin during 
mitosis, association of BET proteins to mitotic chromosomes constitutes an intriguing 
feature. The presence of two tandem bromodomains might explain this ability. 
However, other factors with tandem bromodomains dissociate from mitotic 
chromosomes (for instance TAFII250, (Kruhlak et al., 2001)), suggesting that additional 
structural features in BET proteins might account for this behavior. In this regard, we 
have identified the motif B as a dimerization domain involved in association to mitotic 
chromosomes and proper recognition of acetylated chromatin by BET proteins. 
 
Role of the motif B in chromatin recognition 
While single bromodomains from Brd2 have been shown to attach to histone peptides in 
vitro (Huang et al., 2007; Nakamura et al., 2007; Umehara et al., 2010a; Umehara et al., 
2010b), we have observed chromosome dissociation of a construction encompassing 
both intact bromodomains in the cell, highlighting the relevance of other structural 
characteristics in the context of the full-length protein for chromatin association in vivo. 
In this regard, the motif B seems to be specifically required for chromosome 
association, since deletions of similar extent, N-terminal or C-terminal to the motif B, 
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do not affect Brd2 behavior or function. It is surprising that the ∆mB protein dissociates 
from chromosomes at early mitosis but significantly reassociates at the end. 
Interestingly, previous reports have shown a generalized deacetylation of the chromatin 
at the onset of mitosis and a progressive reacetylation at late mitosis (Kruhlak et al., 
2001; Sasaki et al., 2009). Altogether, this suggests that the requirement of the motif B 
might rely on the acetylation status of the chromatin. TSA-mediated reassociation 
observed at early mitosis supports this idea and highlights the relevance of the motif B 
under hypoacetylation conditions, as it occurs during mitosis. However, despite 
chromosome reassociation of the ∆mB construct observed at late mitosis our data 
indicate that the motif B is required for efficient recognition of the chromatin 
independently of the cell cycle phase. The easy extraction of the protein from non-
synchronous cells at low salt concentrations, the lost of ChIP of cyclins A2 and D1 
promoters, the impaired association to acetylated histone peptides in vitro and the lack 
of activity of the ∆mB construct in functional analysis support this notion. Apparent 
discrepancy between chromosome association of this construct at late mitosis or in the 
presence of TSA at early mitosis and impaired binding to full-acetylated histone 
peptides may be explained by the different experimental approaches. Then, we have set 
up in vitro pull down conditions (mainly salt concentration) to discriminate small 
differences in binding capacities of wild type and mutant Brd2. More important, 
although we observe reassociation of the ∆mB protein to chromosomes in 
immunofluorescence experiments, affinity or architecture of associated ∆mB might 
quite differ from that of the wild type protein, as suggest ChIP and differential salt 
extraction experiments in non-synchronous cells. As our data suggest, improper 
reassociation of Brd2 lacking the motif B to the chromatin might have a detrimental 
impact in transcriptional memory. Thus, motif B should be relevant for right functional 
conformation of BET proteins rather than just for physical recognition of acetylated 
chromatin. 
In contrast to Brd4 and Brdt, which preferentially bind histone H4 at the di-
acetylated state (Dey et al., 2003; Moriniere et al., 2009; Sasaki et al., 2009), Brd2 
seems to more efficiently bind mono-acetylated histone H4 at K12 (Ito et al., 2011; 
Kanno et al., 2004). However, additional acetylation marks have been reported to be 
recognized by Brd2, for instance acetyl-K5 and acetyl-K8 on histone H4 (Kanno et al., 
2004; Umehara et al., 2010b). It is worth noting that these marks decrease during 
mitosis (Kruhlak et al., 2001; Sasaki et al., 2009). In addition, here we show binding of 
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Brd2 to a histone H3 peptide acetylated at K9/14. Although several reports suggest 
binding specificities of BET proteins for different acetylation marks, some 
discrepancies are observed in the literature, probably due to different experimental 
approaches (Dey et al., 2003; Ito et al., 2011; Kanno et al., 2004; LeRoy et al., 2008; 
Moriniere et al., 2009; Sasaki et al., 2009; Umehara et al., 2010b). Thus, binding 
specificities have been determined either by in vitro pull-down experiments, SPR 
binding assays or real-time imaging in living cells, and using overexpressed proteins, 
either full-length fusion constructs, chimeric proteins or truncated fragments including 
just the bromodomains (Dey et al., 2003; Huang et al., 2007; Ito et al., 2011; Kanno et 
al., 2004; Moriniere et al., 2009; Nakamura et al., 2007; Sasaki et al., 2009; Umehara et 
al., 2010a; Umehara et al., 2010b). Moreover, as discussed below, our data suggest that 
BET proteins heterodimerize, raising the question about the real binding specificities of 
the endogenous proteins. 
 
Motif B-mediated dimerization of BET proteins 
Several pieces of evidence support a role of the motif B in Brd2 dimerization: i) self-
interaction of the motif B by two-hybrid assay, ii) pull-down of recombinant motif B by 
a GST-motif B fusion protein, iii) motif B-dependent immunoprecipitation of wild type 
Brd2, and iv) significant FRET signal in self-interaction experiments. Function of many 
transcription factors relies on a dimer structure (Amoutzias et al., 2008). It has been 
previously reported that the N-terminal bromodomain (BD1) of Brd2 is involved in 
Brd2 dimerization (Nakamura et al., 2007). However, our results indicate that the motif 
B is as necessary as the BD1 for Brd2 self-interaction. In fact, we show that the motif B 
is crucial for FRET signal. Thus, both BD1 and the motif B might cooperate to display 
the appropriate functional configuration of Brd2 for efficient recognition of specific 
acetylation marks on the chromatin by the bromodomains. Moreover, our results 
indicate that the motif B mediates not only homodimerization but also 
heterodimerization between BET proteins. Immunoprecipitation experiments, two-
hybrid assays and FRET analysis substantiate this notion. It is tempting to speculate that 
homo- and hetereodimerization between the different BET proteins might be involved 
in modulating transcriptional activity associated to these proteins. In fact, the absence of 
functional redundancy between BET proteins despite overlapping patterns of expression 
(Gyuris et al., 2009; Houzelstein et al., 2002; LeRoy et al., 2008; Shang et al., 2009), 
should argue in favor of a relevant role for the heterodimerization of BET proteins. 
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 Sequence of the motif B is highly conserved at the amino acid level among 
different vertebrate BET proteins (Fig. 7A). Analysis of the Brd2 motif B sequence with 
the Jpred3 tool at (http://www.compbio.dundee.ac.uk/www-jpred/) indicates that this 
region is not disordered, and predicts a coiled coil structure. High score for a coiled coil 
structure in this region was confirmed with the COILS tool (Lupas et al., 1991). Thus, a 
score > 96% was obtained for this region with a scanning window of 21 residues, in 
contrast to the low score (< 1%) obtained for surrounding regions or other domains in 
the protein previously shown not to arrange in a coiled coil structure, for instance the 
bromodomains (Huang et al., 2007; Nakamura et al., 2007). Moreover, prediction for 
the motif B was very similar to that for established coiled coils, as the classical leucine 
zipper in the yeast protein GCN4 (> 99%) (O’Shea et al, 1991). COILS analysis and 
alignment of the motif B from vertebrate and non-vertebrate BET proteins indicated the 
conservation of the putative coiled coil through the different species analyzed (Fig. 7B). 
Coiled coils consist of a heptad repeat (abcdefg) with hydrophobic residues at positions 
a and d, and polar solvent-exposed residues at e and g (Grigoryan and Keating, 2008). 
Thus, putative coiled coil in the motif B showed a 3 heptad repeat (Fig. 7B). As coiled 
coils usually mediate dimerization of proteins (Grigoryan and Keating, 2008), this 
finding strongly supports a role of the motif B in dimerization. However, we cannot rule 
out the possibility that other sequences in the motif B, for instance the well-conserved 
basic region C terminal to the coiled coil, could be also relevant for dimer formation 
(Fig. 7B). 
 
Requirement of the motif B for Brd2 function 
Knocking down experiments have demonstrated that BET proteins are necessary for cell 
cycle progression and cyclin D1 expression (LeRoy et al., 2008; Mochizuki et al., 2008; 
Yang et al., 2008). We have shown that ectopic expression of Brd2 is able to sustain 
elevated levels of cyclins A2 and D1 transcripts, which correlates with reduced neuronal 
differentiation and impaired RA-induced arrest of the cell cycle. Similarly, 
overexpression of cyclin D1 in skin keratinocytes has been previously reported to 
interfere with cell differentiation (Burnworth et al., 2006). An essential aspect of our 
results is that all the observed effects associated to the ectopic expression of Brd2 are 
highly impaired in the absence of the motif B, indicating that this domain is essential for 
Brd2 function. The prominent role displayed by BET proteins in cell cycle progression 
tightly links them to tumor development (Crawford et al., 2008; Filippakopoulos et al., 
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2010; French, 2012; French et al., 2003; French et al., 2008; Greenwald et al., 2004; 
Zuber et al., 2011). In fact, it has been very recently shown that interfering with 
association of BET proteins to the chromatin by synthetic drugs mimicking specific 
acetylation marks, efficiently counteract cancer progression in mice models (Dawson et 
al., 2011; Delmore et al., 2011; Filippakopoulos et al., 2010; Mertz et al., 2011; Prinjha 
et al., 2012; Zuber et al., 2011). In this context, a precise knowledge of structural 
features involved in association of BET proteins to the chromatin will contribute to the 
design of more efficient and specific drugs. 
 
Materials and Methods 
Plasmid constructs and yeast two-hybrid 
All transfection constructs except GFP- and RFP-based constructs were derived from 
vector pAdRSV-S (Giudicelli et al., 2003), with flag or HA tags. GFP- and RFP-based 
constructs were derived from pEGFP-C2 and pDsRed-monomer-N1 vectors (Clontech), 
respectively. The GFP-mB construction was designed with amino acids T463 to I565 of 
Brd2. Mouse Brd2, Brd3 and Brd4 cDNAs were obtained by RT-PCR with RNA 
isolated from P19 cells. Deletion constructs of Brd2 were performed by standard PCR 
techniques and were as follows: WT, amino acids M1-G789; ∆SEED, M1-R770; ∆Cter, 
M1-L721; ∆ET, M1-K612; BD1+2, M1-L472; ∆mB, deletion (∆) of amino acids S505 
to K557; ∆NmB, ∆ S475-E513; ∆CmB, ∆ K572-K619; ∆BD1, ∆ L109-T167. Y152K 
and N428A mutations were also performed by standard PCR. Yeast two-hybrid and X-
gal assays were performed in the DUALhybrid Kit (Biotech) system, using the pLexA-
N bait vector and a day 11 p.c. whole mouse embryo cDNA library cloned in the 
pGAD-HA vector (Biotech), according to manufacturer instructions. Bait construct for 
screening encompassed amino acids T463 to G789 of Brd2, while ET and mB 
constructs encompassed amino acids G607-G789 and T463-I565, respectively. Most 
positive Brd3 clones corresponded to amino acids K402 to K501. Brd3 and Brd4 mB 
constructs encompassed amino acids V432 to K501 and P483 to H552, respectively. 
 
Protein production and purification and pull down assays 
Production of proteins was performed in the E. coli BL21 strain and purification as GST 
fusions was achieved by incubation with Glutathione Sepharose 4B matrix (GE 
Healthcare). GST was excised with PreScission protease (GE Healthcare) when 
required. GST-mB and GST-flag-mB constructions encompassed amino acids E482 to 
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A595 of Brd2, while GST-flag-NET encompassed amino acids T620 to G720. Pull-
down experiments with immobilized GST fusion protein or acetylated histone peptides 
were conducted as previously described (Garcia-Dominguez et al., 2008). For peptide 
pull-down we used biotinylated acetylhistone H3 (acetyl-K9/K14, Upstate Millipore) 
and streptavidin-coupled magnetic beads (Dynabeads M-280 Streptavidin, DYNAL, 
Invitrogen). 
 
Cell culture, transfections and flow citometry 
Human 293T and mouse P19 cells were cultured in Dulbecco's modified Eagle's 
medium supplemented with 10% fetal bovine serum and α-modified Eagle's medium 
supplemented with 7.5% calf and 2.5% fetal bovine sera (PAA), respectively. 
Transfections were performed with Lipofectamine 2000 (Invitrogen) 36 h before 
harvesting cells. Except when indicated, trichostatin A (TSA) was used at 500 ng/ml for 
4 h. For cyclin analysis under normal growth conditions, P19 cells were deprived of 
serum for 48h and harvested 18 h after serum re-addition, as previously described 
(Sinha et al., 2005). All trans retinoic acid (RA) was used at 0.5 µM for 18h. For 
transfection monitoring, the green fluorescent protein expression vector pEGFP-N1 
(Clontech) was used. Cell cycle profiles of propidium iodide-treated cells were analyzed 
using a flow citometry FACScalibur apparatus (BD Bioscience). 
 
Differential salt extraction, immunoprecipitation 
For differential salt extraction, P19 cells were first extracted with buffer A (50 mM 
Tris-HCl pH 7.5, 1% Triton X-100, Complete protease inhibitor cocktail (Roche)) 
supplemented with 100 mM NaCl. Then, pellet was extracted with the same buffer 
containing 520 mM NaCl. For immunoprecitation, 9·105 293T cells were extracted with 
250 µl of buffer A containing 150 mM NaCl. Then, NaCl concentration was increased 
to 600 mM dropwise. Supernatant was recovered and 3-fold diluted with buffer B (50 
mM Tris-HCl pH 7.5, Complete protease inhibitor cocktail (Roche)) for over night 
incubation with anti-flag M2 Affinity Gel (SIGMA). After washing, proteins were 
eluted with 20 µl of SDS-containing Laemmli buffer and analyzed by western blot. 
 
Antibody generation and western blot 
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Antibodies against Brd2 were produced in rabbit after immunization with a peptide 
corresponding to amino acids 698 to 780 of the mouse Brd2 protein. Western blot was 
conducted on PVDF membrane (Bio-Rad) according to manufacturer instructions. 
Antibodies: rabbit anti-Brd2 (1:500), mouse anti-flag M2 (1:2000, SIGMA), rat 
monoclonal anti-HA (1:2000, Roche), goat anti-rabbit, anti-rat and anti-mouse HRP-
conjugated antibodies (1:10 000, SIGMA). 
 
Chromatin immunoprecipitation and quantitative PCR 
A total of 107 cells fixed in 1% formaldehyde for 10 min at 37ºC were used in each 
experiment.  The chromatin was immunoprecipitated with the anti-flag M2 Affinity Gel 
(SIGMA). Quantitative PCR was used for analysis of the CcnD1 and CcnA2 promoters 
and determination of gene expression levels. Total RNA was isolated with the RNAsy 
kit (QIAGEN). Retrotranscription of RNA was performed with the Superscript III 
enzyme (Invitrogen). Real time PCR reactions were performed with the SensiMix 
SYBR Low-ROX kit (BIOLINE) in the Applied Biosystems 7500 FAST Real-Time 
PCR System. Endogenous GAPDH and transfected GFP were used for normalization. 
Algorisms for calculation of relative units and normalization of values according to 
primer efficiency have been previously described (Pfaffl, 2001). Sequence of primers 
was as follows: CcnA2-F, 5’-CTTGGCTGCACCAACAGTAA-3’; CcnA2-R, 5’-
AGCAATGAGTGAAGGCAGGT-3’; CcnD1-F, 5’-TCAAGACGGAGGAGACCTGT-
3’; CcnD1-R, 5’-CTCCTCTTCGCACTTCTGCT-3’; GAPDH-F, 5’-
AACTTTGGCATTGTGGAAGG-3’; GAPDH-R, 5’-
GGATGCAGGGATGATGTTCT-3’; GFP-F, 5’-CAAGATCCGCCACAACATCG-3’; 
GFP-R, 5’-GTCCATGCCGAGAGTGATCC-3’; A2prom-F, 5’-
CCAGCGTTTCCCTATGTTGT-3’; A2prom-R, 5’-CTAGGCAGGAGCGTATGGAT-
3’; D1prom-F, 5’-GGAGGACCCTCTTAGGGAAA-3’; D1prom-R, 5’-
CGGACTGCTTCTCTCCAAAC-3’. 
 
In ovo electroporation, immunofluorescence and FRET 
Electroporation, preparation of embryos and immunofluorescence on neural tube 
sections or P19 cells were conducted as described previously (Farah et al., 2000; 
Garcia-Dominguez et al., 2003). For electroporation monitoring, the green fluorescent 
protein expression vector pEGFP-N1 (Clontech) was used at a concentration of 0.3 
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µg/µl. Antibodies: mouse anti-flag M2 (1:250, SIGMA), rabbit anti-neuron specific 
ßIII-tubulin (1:500, abcam), donkey anti-mouse and anti-rabbit DyLight-549 (1:800, 
Jackson Immunoresearch). Cell nuclei were exposed by DAPI staining. Fluorescent 
images were acquired on a Leica confocal microscope TCS SP5. FRET analysis 
conducted in P19 cells was based on green and red fluorescent proteins (GFP, RFP) and 
analyzed with the Leica Application Suite Advanced Flourescence Software. An RFP-
Brd2 construction derived from plasmid pDsRed-monomer-Hyg-N1 (Clontech) was 
assayed together with different GFP based constructions derived from plasmid pEGFP-
C2 (Clontech). A HCX PL APO lambda blue 63x 1.4 OIL objective was used and the 
following wavelengths were recorded: the green channel (donor excitation/donor 
emission= 488 nm/496-526 nm. AOTF 21%), the red channel (acceptor 
excitation/acceptor emission= 543 nm/579-661 nm. AOTF 40%) and the FRET channel 
(donor excitation/acceptor emission= 488 nm/535-577 nm). A ratiometric calculation of 
FRET and donor signals was obtained. 
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Figure legends 
Fig. 1. A small conserved motif is involved in attachment of Brd2 to mitotic 
chromosomes. (A) Diagram of the different constructs of Brd2 analyzed in this work. 
Numbering under the schema indicates position of the relevant domains, while 
numbering on the right indicates amino acids comprised or deleted (∆) in the different 
constructions. (B) Localization of transfected flag-tagged constructs of Brd2 in P19 
cells harboring the indicated deletions or point mutations was visualized by 
immunofluorescence with anti-flag antibodies (red). Images correspond to cells in 
prophase to metaphase. DNA was counterstained by DAPI (blue). (C) Constructions 
with serial deletions of Brd2 from the C-terminus or with deletions around the motif B 
were analyzed as in (B). BD1, bromodomain 1; BD2, bromodomain 2; mB, motif B; 
YKNA, Brd2 Y152KN428A mutant. Images are representative of more than 90% of 14 
to 25 cells analyzed per construction. Scale bar 10 µm. 
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Fig. 2. The motif B is required for proper association of Brd2 to the acetylated 
chromatin. (A) Flag-tagged versions of Brd2 WT and ΔmB were transfected and 
visualized in P19 cells as indicated in Fig. 1 during prophase/metaphase (early mitosis) 
or anaphase/telophase (late mitosis). (B) P19 cells were transected with the indicated 
flag-tagged constructs and treated (+) or not (-) with TSA. Localization of the constructs 
was analyzed as in (A). Images are representative of more than 90% of 14 to 25 cells 
analyzed per construction. Scale bar 10 µm. (C) Flag-tagged versions of the indicated 
constructs were expressed in P19 cells. Then, proteins were consecutively extracted 
with the indicated NaCl concentrations. The presence of flag-tagged proteins in the 
different extracts was detected by western blot. (D) Pull-down experiments were carried 
out with immobilized diacetylated histone H3 tail peptide and protein extracts from P19 
cells transfected with flag-tagged versions of the indicated constructs. Precipitated flag-
tagged proteins (retained) were detected by western blot. 20% of input protein is also 
shown. 
 
Fig. 3. BET proteins dimerize through the conserved motif B. (A) Growth on non-
selective and selective media of yeast harboring bait construction used for the two-
hybrid screening with Brd2 (pLexA-N vector, Lex), positive clone corresponding to a 
fragment of Brd3 (pGAD-HA vector, GAD), or empty vectors (-), as indicated. 
Constructs used are depicted in (B) and indicated as a, b, c. (B) Interaction between the 
indicated bait (Lex) and prey (GAD) constructs was visualized by blue color in yeast 
assayed for ß-galactosidase activity. All bait constructs correspond to Brd2, and all prey 
constructs to Brd3, except when indicated. (C) Pull-down experiments were carried out 
with immobilized purified glutathione S-transferase (GST) or a GST-motif B (GST-
mB) fusion and flag-tagged motif B (fl-mB) or flag-tagged NET (fl-NET) peptides 
purified from bacteria. Precipitated flag-tagged proteins (retained) were detected by 
western blot. 20% of flag-tagged input protein detected by western blot and 100% of 
GST-derived input protein revealed by Coomassie Blue stain is also shown. (D) 
Extracts from 293T cells transfected with flag-tagged Brd2 (fl-Brd2) and the indicated 
Haemagglutinin (HA)-tagged Brd2 wild type or mutant constructs were 
immunoprecipitated with anti-flag antibodies and co-immunoprecipitated proteins (IP) 
were visualized by western blot with anti-HA antibodies. YK, Brd2 Y152K mutant. (E) 
Extracts from 293T cells transfected with flag-tagged Brd2 (fl-Brd2) and the indicated 
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Haemagglutinin (HA)-tagged Brd constructs were immunoprecipitated with anti-flag 
antibodies and co-immunoprecipitated proteins (IP) were visualized by western blot 
with anti-HA antibodies. (F) Extracts from 293T cells transfected with flag-tagged WT 
(fl-WT) or ∆mB (fl-∆mB) Brd2 constructs and a Haemagglutinin (HA)-tagged Brd3 
construct were immunoprecipitated with anti-flag antibodies and co-
immunoprecipitated proteins (IP) were visualized by western blot with anti-HA 
antibodies. 10% of flag- or HA-tagged input proteins is also shown in (D-F). (G) 
Esquematic representation of Brd2 constructions analyzed in (H) and peptide (antigen) 
used for generation of anti-Brd2 antibodies. (H) Extracts from P19 cells transfected 
with the indicated flag (fl)-tagged Brd2 deletion constructs were immunoprecipitated 
with anti-flag antibodies. Co-immunoprecipitated endogenous Brd2 was monitored by 
western blot with anti-Brd2 antibodies produced in rabbit. 10% of flag-tagged or 
endogenous Brd2 input proteins is also shown. 
 
Fig. 4. Dimerization of BET proteins in the cell. (A) FRET analysis in P19 cells 
expressing a fusion Red Fluorescent Protein (RFP)-Brd2 and Green Fluorescent Protein 
(GFP) fusions of the indicated constructs. YK, Y152K point mutation in Brd2. (B) 
Quantification of FRET. Data correspond to means ± s.d. from 5 independent 
experiments. Statistical significance was analyzed using the Student’s t-test: p values 
for the differences respect to the control YK∆mB construct: *<0.001, **=0.6. (C) 
Localization of transfected flag-Brd2 (red) in P19 cells expressing GFP (green) or a 
GFP-motif B (mB) fusion protein visualized by immunofluorescence. DNA was 
counterstained by DAPI (blue). Images are representative of 7 out of 8 cells analyzed. 
Scale bar 10 µm. 
 
Fig. 5. Deletion of the motif B impairs effects of ectopic Brd2 on the cell cycle. (A) 
Relative levels of expression of the CcnA2 and CcnD1 genes as determined by real time 
PCR in P19 cells transfected with the indicated constructs and subjected to serum 
stimulation. Levels were normalized to cells transfected with empty vector (-). (B) 
Levels of association of the indicated flag-tagged constructs to the CcnA2 and CcnD1 
promoters in P19 cells determined by chromatin immunoprecipitation (ChIP) with anti-
flag antibodies. Levels were normalized to cells transfected with WT Brd2. (C) Relative 
levels of expression of the CcnA2 and CcnD1 genes determined as in (A) in P19 cells 
transfected with the indicated constructs and treated (+) or not for 18 h with all-trans 
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retinoic acid (RA). Levels were normalized to non-treated cells transfected with empty 
vector (-). (D) Cell cycle profiles determined by flow citometry of P19 cells transfected 
with the indicated constructs or empty vector (-) and treated or not with RA as in (C). 
(E) Ratio of cells in G1 respect to cells in the S, G2 and M phases from cell cycle 
profiles has been represented. Values are means ± s.d. from 3 to 5 independent 
experiments in triplicate (A-C) or means ± s.d. from 4 independent experiments (E). 
YKNA, Brd2 Y152KN428A mutant. Statistical significance was analyzed using the 
Student’s t-test: (A) p value for the differences between control (-) and WT or ∆NmB 
constructs ≤0.01; control vs ∆mB or YKNA ≥0.45. (B) WT vs ∆mB or YKNA <0.001; 
WT vs ∆NmB ≥0.5. (C) RA treated vs non treated control cells <0.005; control vs WT 
or ∆NmB in the presence of RA <0.02; control vs ∆mB or YKNA in the presence of RA 
≥0.4. (D) due to RA treatment of control (-) and ∆mB <0.02; due to RA treatment of 
WT =0.58; for the differences between control, WT and ∆mB before RA treatment 
≥0.3; WT vs control or ∆mB after RA treatment <0.02; control vs ∆mB after RA 
treatment =0.35. (F) Western blot showing expression levels of the different flag-tagged 
constructs used in (A-E) transfected in P19 cells; 10 µg of total protein were loaded per 
lane. 
 
Fig. 6. The motif B is required for Brd2-mediated interference of neuronal 
differentiation. (A) P19 cells were transfected with NeuroD2 and E12 expression 
constructs, together with a GFP reporter and the indicated Brd2 constructs, and were 
tested for expression of the neuronal marker ßIII-tubulin. Neurogenesis was evaluated 
as the percentage of transfected cells (GFP (green) positive), which are ßIII-tubulin 
positive (red). DNA was counterstained by DAPI (blue). Scale bar 50 µm. (B) The 
neural tube of chick embryos at stage HH17 was electroporated on the right side with 
the indicated constructs and neurogenesis was evaluated by immunofluorescence after 
30 h on transversal sections of the spinal cord. In this case, neurogenesis was evaluated 
as the percentage of transfected cells (GFP (green) positive), which have left the 
proliferative or ventricular zone (VZ) and have migrated to the differentiation 
compartment or mantle layer (ML), where the neuronal marker βIII-tubulin (red) is 
expressed. Frontier between VZ and ML is indicated by a dashed line in the 
electroporated side of the GFP control experiment (left hand panel). (C) Representation 
of the percentage of neurogenesis determined as indicated in (A) (P19 cells) and (B) 
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(neural tube). Values are means ± s.d.; 2-3 areas from 4 independent experiments were 
analyzed for P19 cells and 3 to 4 sections from 5 independent experiments for the neural 
tube. Representative images are displayed. Statistical significance was analyzed using 
the Student’s t-test:  p values for the differences with control GFP were *<0.01, 
**=0.37, ***<0.02, ****=0.75. 
 
Fig. 7. The conserved motif B contains a putative coiled coil. (A) Amino acid 
sequence of different BET proteins from vertebrate, corresponding to a region located 
between the bromodomains and the ET domain, were aligned. Amino acids conserved 
in all the sequences have been boxed in black, while amino acids conserved in 6 of the 8 
sequences have been marked in grey. The indicated conserved region constitutes the 
motif B (Paillisson et al., 2007). (B) The motif B of different Brd2 proteins from 
vertebrate, and BET proteins from drosophila and yeast were aligned. A putative coiled 
coil structure with a 3 heptad repeat (I, II, III) has been marked. Black boxes indicate 
relevant non-polar residues in the heptad repeat, while grey boxes indicate putative 
solvent-exposed residues in the heptad repeat (Grigoryan and Keating, 2008). The 
conserved basic region at the C terminus of the motif B is also indicated. Alignments 
were performed with the ClustalX 2.0.11 application. Coiled coil prediction was 
performed with the COILS tool at 
(http://www.ch.embnet.org/software/COILS_form.html). Amino acid positions of the 
aligned sequences are indicated at left and right hand of each sequence. Accessions and 
abbreviations are as follows: human Brd2 (hBrd2), NM_001113182; human Brd3 
(hBrd3), NM_007371; human Brd4 (hBrd4), NM_014299; human Brdt (hBrdt), 
NM_001242805; mouse Brd2 (mBrd2), NM_001204973; chicken Brd2 (cBrd2), 
NM_001030674; Xenopus Brd2 (xBrd2), BC084758; Medaka Brd2 (oBrd2), 
AB183488; Drosophila Fsh (dFsh), NM_078523; yeast Bdf1 (yBdf1), NM_001182287; 
yeast Bdf2 (yBdf2), NM_001180129. 
 
Legends to supplementary figures 
Fig. S1. The motif B is required for attachment of BET proteins to mitotic 
chromosomes. (A) Location of the indicated flag-tagged constructs of Brd3 and Brd4 
in P19 cells visualized by immunofluorescence with anti-flag antibodies (red). (B) P19 
cells were transfected with the indicated flag-tagged constructs and treated (+) or not (-) 
with 500 ng/ml TSA. (C) Association of the ∆mB construction to the chromosomes was 
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analyzed as in (A) in the presence of 5, 25, 75 and 150 ng/ml TSA. DNA was 
counterstained by DAPI (blue). Images are representative of more than 90% of 14 to 25 
cells analyzed per experiment. Scale bar 10 µm. 
 
Fig. S2. Dimerization between BET proteins. (A) Interaction between bait (Lex) and 
prey (GAD) constructs corresponding to the indicated motives B was visualized by blue 
color in yeast assayed for ß-galactosidase activity. (B) Protein extracts from 293T cells 
transfected with the indicated flag (fl)-Brd2 and Haemagglutinin (HA)-tagged 
constructs were immunoprecipitated with anti-flag antibodies and co-
immunoprecipitated proteins (IP) were visualized by western blot with anti-HA 
antibodies. 10% of flag- or HA-tagged input proteins is also shown. 
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